Shelter Pharma Ltd

Independent Director Regularization

• Regularization of Vinita Shivraj Gadhavi as Non-Executive Independent Director for five-year term.
• Term: 31 July 2026 to 30 July 2031; not liable to retire by rotation.
• Shareholders approved the designation change at the AGM held 29 September 2026.
• Reason: change in designation from Additional Director to Non-Executive Independent Director.
• Profile: entrepreneur and healthcare professional with over 12 years in pharma, quality, and R&D.
• DIN: 09102407; not related to other directors and not debarred.
• Impact: strengthens independent director presence; term tenure aligned with governance.

AGM Details

• Date: 29 September 2026; time 10:00–11:00 AM.
• Mode: in-person AGM with remote e-voting.
• Place: Shelter Nagar, Himmatnagar, Gujarat.
• Record date: 22 September 2026.
• Shareholders on record: 1,074.

Resolutions presented

• Resolution 1: Adopt Audited Financial Statements for year ended 31 Mar 2026.
• Resolution 2: Re-appoint Parvezbanu Mohamed Rafiq Idariya by rotation.
• Resolution 3: Ratify Related Party Transactions for FY 2025-26.
• Resolution 4: Approve RPT with Gandhi Brothers for FY 2026-27.
• Resolution 5: Approve RPT with Shelter Pharmacy Pvt Ltd for FY 2026-27.
• Resolution 6: Approve RPT with Al Nasheet Global Business Pvt Ltd for FY 2026-27.
• Resolution 7: Regularize Vinita Shivraj Gadhavi as Non-Executive Independent Director.

Voting outcomes

• Resolution 1: Passed; 100% in favour of votes polled.
• Resolution 2: Passed; 100% in favour of votes polled.
• Resolution 3: Passed; 100% in favour of votes polled.
• Resolution 4: Passed; 100% in favour of votes polled.
• Resolution 5: Passed; 100% in favour of votes polled.
• Resolution 6: Passed; 100% in favour of votes polled.
• Resolution 7: Passed; Special resolution with 100% in favour.

Dividend

• Dividend: No dividend proposed or declared.

Director changes

• Regularization of Vinita Shivraj Gadhavi as Non-Executive Independent Director.

Auditor appointments

• Auditors: No changes disclosed.

Material Related Party Transactions

• Gandhi Brothers: Material RPT for FY 2026-27.
• Shelter Pharmacy Pvt Ltd: Material RPT for FY 2026-27.
• Al Nasheet Global Business Pvt Ltd: Material RPT for FY 2026-27.

Other material approvals

• Special resolution for Regularization of Additional Director as Independent Director.

AGM details

• Date and time: 29 September 2026 at 10:00 A.M.; physical meeting at registered office.
• Mode: physical with e-voting facility; ballots available at venue.

Resolutions put to vote

• Adopt Audited Standalone Financial Statements for FY2026 with Directors' and Auditors' Reports (Ordinary).
• Appoint Parvezbanu Mohamed Rafiq Idariya as Non-Executive Director by rotation (Ordinary).
• Ratify related party transactions entered during FY2025-2026 (Ordinary).
• Approve related party transactions with Gandhi Brothers for FY2026-27 (Ordinary).
• Approve related party transactions with Shelter Pharmacy Pvt Ltd for FY2026-27 (Ordinary).
• Approve related party transactions with Al Nasheet Global Business Pvt Ltd for FY2026-27 (Ordinary).
• Regularization of Vinita Shivraj Gadhavi as Non-Executive Independent Director (Special).

Voting status

• Results to be announced within 48 hours of conclusion.
• Will be uploaded on company and BSE websites.

Director changes

• Parvezbanu Mohamed Rafiq Idariya appointed as Non-Executive Director.
• Vinita Shivraj Gadhavi Regularized as Non-Executive Independent Director.

Material Related Party Transactions

• Material RPTs with Gandhi Brothers, Shelter Pharmacy Pvt Ltd, and Al Nasheet Global Business Pvt Ltd for FY2026-27.

Auditors and Scrutinizer

• Representatives of Statutory, Internal, and Secretarial Auditors attended; no changes disclosed.
• Scrutinizer appointed for e-voting: Murtuza Mandorwala.

Shelter Pharma Limited – Trading window closes from Thursday, October 01, 2026 till 48 hours after the announcement of the Un-audited Financial Results for the Half year ended on September 30, 2026.

Positive doctor feedback for Human Healthcare products

• Dr. C. M. Patel shared positive reviews of the products on social media.
• Products cited: Lemonade Barley Water, Alkaliser syrup, Joemega capsules.
• Feedback highlights effectiveness, quality, and 100% natural composition.
• Affirmed acceptance among medical professionals and consumers.
• Impact on brand credibility and trust across the human healthcare portfolio.
• No immediate material impact expected on financials.

Order details

• Awarding entity: Berlin International Company.
• Nature and scope: supply D3 CURE 50 ML nutraceuticals; 3,500 units at USD 2.90 each.
• Value: USD 10,150 (Rs 9,72,360.86).
• Entity is international; export order.
• Execution: within mutually agreed PO timelines.
• Promoter/related party: No interest; no related party transactions.
• Material impact: expected revenue growth and broader international presence post-execution.

Participation in Ayurveda Exhibition

• Shelter Pharma to participate in Vishwa Ayurveda Parishad Exhibition in Jaipur on 17-18 Sept 2026.
• Company stall will showcase its pharmaceutical and healthcare portfolio to Ayurveda physicians and researchers.
• Event organized by Vishwa Ayurveda Parishad in association with National Institute of Ayurved (NIA), Jaipur.
• Theme: Role of Ayurveda in Lifestyle Disorders.
• No financial investment or revenue impact disclosed for participation.

AGM Details

• 19th AGM to be held on 29 September 2026 at 11:00 AM IST at registered office, physical meeting.
• Venue: Shelternagar, Nr. Bus Station, Himatnagar-383001 Gujarat.

Board decisions and governance

• Vinita Shivraj Gadhvi appointed as Non-Executive Independent Director for five years.
• Term from 31 July 2026 to 30 July 2031, subject to shareholder approval.
• Not liable to retire by rotation during tenure.
• Parvezbanu Mohamed Rafiq Idariya reappointed as Director.
• Ratification of related party transactions for FY2025-26.
• Approval of material related party transactions for FY2026-27, subject to shareholders.
• 19th AGM scheduled for 29 September 2026 at 10:00 AM.
• Notice for AGM and annual report approved; MDAR and Directors' Report included.
• Cut-off dates fixed for AGM eligibility and remote e-voting.
• Scrutinizer appointed: Murtuza Mandorwala & Associates.

Director appointment

• Regularization of Vinita Gadhavi as Non-Executive Independent Director for five years (31 Jul 2026–30 Jul 2031).
• Change in designation from Additional Director to Non-Executive Independent Director.
• Term subject to shareholders' approval; tenure not liable to retirement by rotation.
• Board approved on 1 September 2026, with subsequent shareholder approval required.
• Brief profile: entrepreneur and healthcare professional with 12+ years in pharma, healthcare, and regulation.
• Educational background: Ph.D., MBA, B.Pharm, M.Pharm (Gold Medal).
• Disclosure of relationship: not related to other directors.
• Not debarred from holding office as director per SEBI.
• Effective date of appointment: 31 July 2026.